Backenroth Samuel

CIK 00015798872 companiesNEW YORK, NY

Transactions

Companies

Filings

CIK

0001579887

Recent Transactions

14 trades

Exercise/Conversion
Notable Labs, Ltd.
Restricted Stock Units
2023-03-31−525,000→ 175,000 total
Exercise/Conversion
Notable Labs, Ltd.
Ordinary Shares
2023-03-31+525,000→ 525,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-12-29+41,915→ 41,915 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-04-30$6.00/sh+1,000→ 11,630 total
Other
NeuBase Therapeutics, Inc.
Employee stock option (right to buy)
2019-07-12+3,000→ 0 total
Award
NeuBase Therapeutics, Inc.
Employee stock option (right to buy)
2019-07-12+772,923→ 772,923 total
Award
NeuBase Therapeutics, Inc.
Stock Option (right to buy)
2017-10-16+350,000→ 350,000 total
Purchase
NeuBase Therapeutics, Inc.
Warrants (right to buy)
2017-04-10+50,001→ 50,001 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2017-04-10$0.70/sh+71,429→ 212,596 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.87/sh+450→ 139,167 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.71/sh+200→ 141,167 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.88/sh+8→ 138,717 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.89/sh+10→ 138,709 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.84/sh+1,800→ 140,967 total

C/O OHR PHARMACEUTICAL INC. 800 THIRD AVE., 11TH FLOOR

NEW YORK, NY, 10022